A double blind, randomized, placebo-controlled, parallel study to evaluate the efficacy and safety of Androgel [testosterone], as an adjunct to oral hypoglycemic therapy, in the treatment of hypogonadal and low testosterone men with type 2 diabetes.

Trial Profile

A double blind, randomized, placebo-controlled, parallel study to evaluate the efficacy and safety of Androgel [testosterone], as an adjunct to oral hypoglycemic therapy, in the treatment of hypogonadal and low testosterone men with type 2 diabetes.

Completed
Phase of Trial: Phase II

Latest Information Update: 23 Jan 2015

At a glance

  • Drugs Testosterone (Primary)
  • Indications Hypogonadism
  • Focus Pharmacodynamics
  • Most Recent Events

    • 07 Sep 2007 Status changed from in progress to completed.
    • 12 Jan 2007 Status change
    • 19 Nov 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top